To better understand the complexity of NF-κB action and lung cancer pathogenesis for better design of NF-κB–targeted therapy against this deadliest cancer, it is thus of importance and interest to determine the roles of NF-κB2 as well. The gene discussed is NFKB1; the disease is lung carcinoma.